$ZBIO
Zenas BioPharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Zenas BioPharma, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ZBIO down today? It is at $23.00, -4.75% on the day and -3.56% after hours, and our scanner flagged it 114 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ZBIO spikes, and full due diligence on ZBIO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ZBIO 114 times in the last 30 days. Create a free account to track $ZBIO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ZBIO from our scanner (live price and day move above). Our scanner has fired 21 unusual-volume and momentum alerts on ZBIO today, peaking at 64.3x its normal volume.
Likely catalystPriced share offering, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedNov 16, 2026 · 4 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
At-the-market (ATM) program — sells new shares into the market gradually over time · About $200.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Moulder Leon O Jr Officer | Bought (open market) | +60K 0.09% of company | added 3.3% | 1.88M | $1.0M at $16.88 | May 18, 26 |
Moulder Leon O Jr Officer | Bought (open market) | +35K 0.05% of company | added 2.0% | 1.82M | $617K at $17.62 | Apr 29, 26 |
Moulder Leon O Jr Officer | Bought (open market) | +25K 0.04% of company | added 1.4% | 1.75M | $451K at $18.02 | Apr 28, 26 |
Lu Hongbo Director | Bought (open market) | +75K 0.1% of company | added 22% | 423K | $1.5M at $20.00 | Mar 31, 26 |
Moulder Leon O Jr Officer | Bought (open market) | +34K 0.05% of company | added 2.0% | 1.76M | $657K at $19.31 | Mar 31, 26 |
Fairmount Funds Management Llc Director | Bought (open market) | +150K 0.2% of company | added 6.8% | 2.36M | $3.0M at $20.00 | Mar 31, 26 |
Lu Hongbo Director | Bought (open market) | +4K | added 0.9% | 427K | $70K at $18.63 | Mar 31, 26 |
Moulder Leon O Jr Officer | Bought (open market) | +20K 0.03% of company | added 1.2% | 1.69M | $365K at $18.23 | Mar 30, 26 |
Allen Patricia L Director | Bought (open market) | +4K | added 26% | 20K | $110K at $26.36 | Feb 13, 26 |
Allen Patricia L Director | Bought (open market) | +16K 0.02% of company | n/a | 16K | $373K at $23.77 | Feb 12, 26 |
Lu Hongbo Director | Bought (open market) | +26K 0.04% of company | added 8.1% | 348K | $585K at $22.50 | Feb 11, 26 |
Fox Jennifer A. Officer | Acquired (grant/award) | +2K | n/a | 2K | $21K at $13.35 | Feb 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ZBIO from our scanner (live price and day move above). Our scanner has fired 21 unusual-volume and momentum alerts on ZBIO today, peaking at 64.3x its normal volume.
ZBIO last traded at $23.00, down 4.75% on the day and down 3.56% after hours. The price and chart above update live during market hours (4 AM to 8 PM ET).
Yes. ZBIO currently has a dividend yield of about 0.03% ($0.01 per share per year). Dividend figures can change; this is not investment advice.
The ZBIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ZBIO 114 times in the last 30 days.
ZBIO (Zenas BioPharma, Inc. Common Stock) trades on XNAS, with a market cap of about $1.70B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ZBIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ZBIO discussion
Sign in to ask a question or join the discussion.